It has long been known that studies have documented an excess of iron in persons who experience Parkinson’s symptoms. More recent studies posted below confirm this. There is clearly a strong connection between iron accumulation and Parkinsons. But why?
An excess of iron in the body leads to premature cell death and the emergence of chronic illnesses including Parkinsons. One option to discuss with your doctor is to begin giving blood on a regular basis. Regular blood donations depletes the excess of iron in the bloodstream and reverses the acceleration in aging that results.
Aging is a multifactorial process marked by a progressive decline in physiological function and increased vulnerability to neurological diseases. A central feature of aging is inflammaging, a state of chronic low-grade inflammation driven by cellular senescence, mitochondrial dysfunction, and oxidative stress.
Both ferroptosis and cuproptosis have emerged as critical mechanisms linking redox imbalance, mitochondrial stress, and disrupted metal homeostasis to age-related pathology. Ferroptosis, an iron-dependent process characterized by lipid peroxidation and impaired glutathione activity and cuproptosis, a copper-dependent mechanism associated with protein lipoylation stress, intersect with aging-related changes in mitochondrial and metabolic function.
Importantly, these two forms of cell death should not be viewed as entirely separate pathways but rather as interconnected axes. Disturbances in copper or iron homeostasis converge to lower cellular survival thresholds, thereby exacerbating oxidative damage, immune dysfunction, and tissue degeneration. This speeds up aging.
******
Research on Iron Accumulation and Parkinsons
J Magn Reson Imaging. 2026 Jan;63(1):196-204.Hemispheric Asymmetry of Neuromelanin-Iron Dysfunction in the Substantia Nigra: MRI-Based Evidence for Lateralized Motor Onset in Early-Stage Parkinson’s Diseas
Abstract
Background: Parkinson’s disease (PD) often presents with lateralized motor symptoms at onset, reflecting asymmetric degeneration of the substantia nigra (SN). Neuromelanin (NM) loss and iron accumulation are hallmarks of SN pathology in PD, but their spatial distribution and interrelationship in PD patients with right-sided (PDR) or left-sided (PDL) motor symptom onset remain unclear.
Purpose: To investigate the spatial vulnerability and interrelationship of NM and iron in the SN among PDR, PDL, and healthy controls (HCs) using MRI.
Study type: Prospective.
Population: 56 early-stage PD patients (28 PDR: 55.93 ± 7.41 years, 16 female/12 male; 28 PDL: 59.04 ± 10.44 years, 13 female/15 male) and 30 age- and gender-matched HCs (57.47 ± 4.07 years, 17 female/13 male).
Field strength/sequence: 3-T, T1-weighted Fast Spoiled Gradient Recalled (FSPGR) and gradient recalled echo (GRE) for quantitative susceptibility mapping (QSM).
Assessment: Voxel-wise group comparisons of NM and iron were performed, and overlapping clusters with co-localized NM loss and iron deposition were identified. Mean cluster values were extracted for subsequent group comparison and NM-iron relationship modeling.
Statistical tests: Welch’s analysis of variance (ANOVA), Chi-squared test, Mann-Whitney U, voxel-wise analysis of covariance (ANCOVA), bidirectional mediation, partial correlation.
Results: Cluster 1 (PDR vs. HC) in left nigrosome-1 showed concurrent NM reduction (1.14 ± 0.09 vs. 1.30 ± 0.06) and iron increase (0.14 ± 0.06 vs. 0.08 ± 0.04 ppm); Cluster 2 (PDL vs. HC) in right nigrosome-1 also showed concurrent NM reduction (1.15 ± 0.06 vs. 1.28 ± 0.07) and iron increase (0.16 ± 0.05 vs. 0.10 ± 0.04 ppm). Bidirectional mediation revealed significant NM-iron direct and indirect effects in PDR and PDL (vs. HCs).
Data conclusion: This study demonstrates contralateral nigrosome-1 as the vulnerable region with concurrent Neuromelanin loss and iron accumulation and exhibits reciprocal mediation effects between Neuromelanin and iron in early-stage PD.
******
Free Radic Biol Med. 2019 Mar:133:221-233. Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration
Abstract
Perturbations in iron homeostasis and iron accumulation feature in several neurodegenerative disorders including Alzheimer’s disease (AD), Parkinson’s disease (PD) and Amyotrophic lateral sclerosis (ALS). Proteins are pathologically associated with neurodegeneration are involved in molecular crosstalk with iron homeostatic proteins.
Quantitative susceptibility mapping, an MRI based non-invasive technique, offers proximal evaluations of iron load in regions of the brain and powerfully predicts cognitive decline. Molecules that target elevated iron have shown promise against PD and AD in preclinical studies and clinical trials.
Despite these strong links between altered iron homeostasis and neurodegeneration the molecular biology to describe the association between enhanced iron levels and neuron death, synaptic impairment and cognitive decline is ill defined.
In this review we discuss the current understanding of brain iron homeostasis and how it may be perturbed under pathological conditions. Further, we explore the ramifications of a novel cell death pathway called ferroptosis that has provided a fresh impetus to the “metal hypothesis” of neurodegeneration.
The removal of iron through chelation or genetic modifications appears to extinguish the ferroptotic pathway. Conversely, tissues that harbour elevated iron may be predisposed to ferroptotic damage. These emerging findings are of relevance to neurodegeneration where ferroptotic signalling may offer new targets to mitigate cell death and dysfunction.
Robert Rodgers PhD
Founder 2004
Parkinsons Recovery®


















